|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
|
US20090061478A1
(en)
*
|
2006-01-30 |
2009-03-05 |
Lene Have Poulsen |
High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
|
|
EP1878744A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
|
|
AU2007353319A1
(en)
|
2006-11-15 |
2008-11-20 |
Invitrogen Dynal As |
Methods for reversibly binding a biotin compound to a support
|
|
WO2008116468A2
(en)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
EP3620465B1
(en)
|
2007-07-03 |
2025-02-19 |
Dako Denmark A/S |
Improved methods for generation, labeling and use of mhc multimers
|
|
EP3124497B1
(en)
|
2007-09-14 |
2020-04-15 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US12529164B2
(en)
|
2007-09-14 |
2026-01-20 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US10611818B2
(en)
|
2007-09-27 |
2020-04-07 |
Agilent Technologies, Inc. |
MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
DK2254592T3
(da)
|
2008-02-28 |
2019-09-09 |
Dako Denmark As |
MHC-multimerer til Borrelia-diagnostik og sygdom
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
JP5686098B2
(ja)
*
|
2009-09-17 |
2015-03-18 |
Jsr株式会社 |
アビジンとビオチン誘導体の解離方法及び解離剤
|
|
EP2567226B1
(en)
|
2010-05-06 |
2016-08-10 |
Adaptive Biotechnologies Corporation |
Monitoring health and disease status using clonotype profiles
|
|
CN103124740B
(zh)
*
|
2010-09-21 |
2015-09-02 |
美国卫生和人力服务部 |
抗-ssx-2t细胞受体和相关材料及使用方法
|
|
WO2012044999A2
(en)
*
|
2010-10-01 |
2012-04-05 |
Ludwig Institute For Cancer Research Ltd. |
Reversible protein multimers, methods for their production and use
|
|
US9023604B2
(en)
|
2011-07-18 |
2015-05-05 |
Iba Gmbh |
Method of reversibly staining a target cell
|
|
WO2013056090A1
(en)
*
|
2011-10-12 |
2013-04-18 |
University Of Connecticut |
Affinity-based materials for the non-destructive separation and recovery of cells
|
|
ES3011307T3
(en)
*
|
2012-02-23 |
2025-04-07 |
Juno Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
|
CN102662054B
(zh)
*
|
2012-05-10 |
2014-08-13 |
东南大学 |
一种同步检测特异性胸腺依赖性淋巴细胞数量和功能的方法
|
|
CN105073770B
(zh)
|
2012-11-16 |
2019-08-06 |
Iba股份有限公司 |
链霉亲和素突变蛋白及其使用方法
|
|
NZ759969A
(en)
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
US9970849B2
(en)
|
2014-01-21 |
2018-05-15 |
Stemcell Technologies Inc. |
Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
|
|
SI3132247T1
(sl)
|
2014-04-16 |
2021-12-31 |
Juno Therapeutics Gmbh |
Postopki, kompleti in naprava za povečanje populacije celic
|
|
CA2946312A1
(en)
|
2014-04-23 |
2015-10-29 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
US11150239B2
(en)
|
2014-04-30 |
2021-10-19 |
Iba Lifesciences Gmbh |
Method of isolating a target cell
|
|
EP3037820A1
(en)
*
|
2014-12-27 |
2016-06-29 |
Miltenyi Biotec GmbH |
Cell detection methods and reagents having a releasable labelling moiety
|
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
|
EP3288570A4
(en)
|
2015-04-29 |
2018-11-21 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
JP6657721B2
(ja)
*
|
2015-09-30 |
2020-03-04 |
ソニー株式会社 |
細胞の分析方法、細胞分析用チップ、細胞分析用試薬、細胞分析用キット及び細胞分析用装置
|
|
MX2018004875A
(es)
|
2015-10-22 |
2018-08-01 |
Juno Therapeutics Gmbh |
Metodos para cultivar celulas y kits y aparatos para ello.
|
|
AU2016341529B2
(en)
*
|
2015-10-22 |
2023-03-30 |
Juno Therapeutics Gmbh |
Methods for culturing cells and kits and apparatus for same
|
|
EP3365453A2
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods, kits, agents and apparatuses for transduction
|
|
EP3443123B1
(en)
|
2016-04-11 |
2021-08-11 |
Board of Regents, The University of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
|
EP3488011A1
(en)
|
2016-06-28 |
2019-05-29 |
Technische Universität München |
Combination of reversible and irreversible cell labeling for analizing receptor-ligand koff rate
|
|
TWI795365B
(zh)
|
2016-08-11 |
2023-03-11 |
荷蘭商凱特製藥歐洲公司 |
製造和使用可溶性主要組織相容性複合體（ｍｈｃ）分子類之方法
|
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
|
EP3336546B1
(en)
|
2016-12-13 |
2020-07-01 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell labelling with conjugates having two releasable binding sites
|
|
EP3336545A1
(en)
|
2016-12-13 |
2018-06-20 |
Miltenyi Biotec GmbH |
Reversible labeling of antigens in biological specimens
|
|
CA3050085A1
(en)
|
2017-01-20 |
2018-07-26 |
Juno Therapeutics Gmbh |
Cell surface conjugates and related cell compositions and methods
|
|
JP7339160B2
(ja)
|
2017-04-27 |
2023-09-05 |
ジュノ セラピューティクス ゲーエムベーハー |
オリゴマー粒子試薬およびその使用方法
|
|
SG11202000606TA
(en)
|
2017-07-29 |
2020-02-27 |
Juno Therapeutics Inc |
Reagents for expanding cells expressing recombinant receptors
|
|
EP3489684B1
(en)
|
2017-11-27 |
2024-06-26 |
Miltenyi Biotec B.V. & Co. KG |
Method for photobleaching stained cells
|
|
CN119193493A
(zh)
|
2017-12-08 |
2024-12-27 |
朱诺治疗学股份有限公司 |
生产工程化t细胞组合物的过程
|
|
CN116148467A
(zh)
*
|
2017-12-12 |
2023-05-23 |
清华大学 |
检测翻译后修饰蛋白质与其配体间相互作用的成套试剂
|
|
US12516099B2
(en)
|
2018-08-09 |
2026-01-06 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
|
US20210246189A1
(en)
|
2018-09-03 |
2021-08-12 |
Technische Universitaet Muenchen |
A double peptide tag combining reversibility and flexible functionalization
|
|
SG11202102108QA
(en)
|
2018-09-11 |
2021-04-29 |
Juno Therapeutics Inc |
Methods for mass spectrometry analysis of engineered cell compositions
|
|
SG11202104355SA
(en)
|
2018-10-31 |
2021-05-28 |
Juno Therapeutics Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
|
ES2968737T3
(es)
|
2018-11-06 |
2024-05-13 |
Juno Therapeutics Inc |
Proceso para producir células T manipuladas genéticamente
|
|
WO2020127222A2
(en)
|
2018-12-17 |
2020-06-25 |
Immudex Aps |
Panel comprising borrelia mhc multimers
|
|
CA3136348A1
(en)
*
|
2019-04-09 |
2020-10-15 |
Nurix Therapeutics, Inc. |
3-substituted piperidine compounds for cbl-b inhibition, and use of a cbl-b inhibitor in combination with a cancer vaccine and/or oncolytic virus
|
|
WO2020207963A1
(en)
|
2019-04-12 |
2020-10-15 |
Miltenyi Biotec B.V. & Co. KG |
Conjugates having an enzymatically releasable detection moiety and a barcode moiety
|
|
AU2020278592B2
(en)
|
2019-05-17 |
2024-10-10 |
Nurix Therapeutics, Inc. |
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
|
|
CA3142108A1
(en)
|
2019-05-28 |
2020-12-03 |
Miltenyi Biotec B.V. & Co. KG |
Method for generation of genetically modified t cells
|
|
CN114207136A
(zh)
|
2019-06-07 |
2022-03-18 |
朱诺治疗学股份有限公司 |
自动化t细胞培养
|
|
MX2021015675A
(es)
|
2019-06-26 |
2022-02-03 |
Nurix Therapeutics Inc |
Compuestos de bencil-triazol sustituidos para la inhibicion de cbl-b y otros usos de los mismos.
|
|
AU2020320195A1
(en)
|
2019-07-30 |
2022-03-10 |
Nurix Therapeutics, Inc. |
Urea, amide, and substituted heteroaryl compounds for Cbl-b inhibition
|
|
KR20220073738A
(ko)
|
2019-08-30 |
2022-06-03 |
주노 쎄러퓨티크스 인코퍼레이티드 |
세포 분류를 위한 기계 학습 방법
|
|
WO2021047804A1
(en)
|
2019-09-11 |
2021-03-18 |
Miltenyi Biotec B.V. & Co. KG |
In vitro method for transduction of t cells in the presence of malignant cells
|
|
KR20220101641A
(ko)
|
2019-10-30 |
2022-07-19 |
주노 테라퓨틱스 게엠베하 |
세포 선택 및/또는 자극 장치 및 사용 방법
|
|
EP4078178B1
(en)
|
2019-12-20 |
2024-10-23 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell detection via mhc with conjugates having an enzymatically cleavable detection moiety
|
|
JP2023512209A
(ja)
|
2020-01-28 |
2023-03-24 |
ジュノー セラピューティクス インコーポレイテッド |
Ｔ細胞形質導入のための方法
|
|
WO2021152178A1
(en)
|
2020-01-31 |
2021-08-05 |
Cell.Copedia GmbH |
Methods of isolating a biological entity
|
|
IL295384B1
(en)
|
2020-02-12 |
2026-04-01 |
Juno Therapeutics Inc |
T-cell preparations with chimeric antigen receptor directed against CD19 and methods and uses thereof
|
|
IL295381B1
(en)
|
2020-02-12 |
2026-04-01 |
Juno Therapeutics Inc |
BCMA-directed chimeric T-cell antigen receptor compounds and methods and uses thereof
|
|
CN115835873A
(zh)
|
2020-05-13 |
2023-03-21 |
朱诺治疗学股份有限公司 |
用于产生表达重组受体的供体分批细胞的方法
|
|
EP3916393B1
(en)
|
2020-05-27 |
2023-01-25 |
Miltenyi Biotec B.V. & Co. KG |
Method for detection of cells by repetitive staining and destaining
|
|
EP4204809A1
(en)
|
2020-08-27 |
2023-07-05 |
Miltenyi Biotec B.V. & Co. KG |
Releasable reagents for cell separation
|
|
WO2022048780A1
(en)
|
2020-09-07 |
2022-03-10 |
Miltenyi Biotec B.V. & Co. KG |
Conjugates having an enzymatically releasable detection moiety and a barcode moiety
|
|
JP2024517863A
(ja)
|
2021-05-06 |
2024-04-23 |
ジュノ・セラピューティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
細胞を刺激し、形質導入する方法
|
|
WO2023017115A1
(en)
|
2021-08-11 |
2023-02-16 |
Iba Lifesciences Gmbh |
Fractionation of cells based on a marker protein
|
|
EP4227423A1
(en)
|
2022-02-09 |
2023-08-16 |
Technische Universität München |
Means and methods for identifying high affinity t-cells
|
|
US20250297282A1
(en)
|
2022-05-05 |
2025-09-25 |
Juno Therapeutics Gmbh |
Viral-binding protein and related reagents, articles, and methods of use
|
|
EP4532695A1
(en)
|
2022-05-25 |
2025-04-09 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
|
WO2024124132A1
(en)
|
2022-12-09 |
2024-06-13 |
Juno Therapeutics, Inc. |
Machine learning methods for predicting cell phenotype using holographic imaging
|
|
JP2026504491A
(ja)
|
2023-02-03 |
2026-02-05 |
ツェー３エス２ ゲーエムベーハー |
操作された免疫細胞の非ウイルス的製造のための方法
|
|
CN121127253A
(zh)
|
2023-02-28 |
2025-12-12 |
朱诺治疗学股份有限公司 |
治疗系统性自身免疫性疾病的细胞疗法
|
|
EP4484441A1
(en)
|
2023-06-26 |
2025-01-01 |
Eberhard-Karls-Universität Tübingen |
Mhc-class i derived polypeptide
|
|
WO2025083196A1
(en)
|
2023-10-18 |
2025-04-24 |
Tq Therapeutics Gmbh |
A method of manufacturing a cellular therapy product and respective kits and devices
|